Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Artemisinin Combination Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sanofi
Ipca Laboratories
Calyx Chemicals and Pharmaceuticals
Ajanta Pharma
Hovid Berhad
Shanghai Fosun Pharmaceutical Industrial Development
Aspen Pharmacare Holdings
Desano Holdings
KPC Pharmaceuticals
Novartis
Cipla
Guilin Pharmaceuticals
By Type:
Artemether-Lumefantrine
Artesunate-Amodiaquine
Others
Artesunate-Sulfadoxine-Pyrimethamine
Artesunate-Pyronaridine
By Application:
Clinic
Hospital
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Artemisinin Combination Therapy Market Overview 2018-2029
-
1.1 China Artemisinin Combination Therapy Industry Development Overview
-
1.2 China Artemisinin Combination Therapy Industry Development History
-
1.3 China Artemisinin Combination Therapy Industry Market Size (2018-2029)
-
1.4 China Artemisinin Combination Therapy Market Analysis by Type from Production Side
-
1.4.1 China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artemether-Lumefantrine (2018-2029)
-
1.4.2 China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Amodiaquine (2018-2029)
-
1.4.3 China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Sulfadoxine-Pyrimethamine (2018-2029)
-
1.4.5 China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Pyronaridine (2018-2029)
-
1.5 China Artemisinin Combination Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.3 China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Artemisinin Combination Therapy Market Analysis by Region
-
1.6.1 North China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Artemisinin Combination Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Artemisinin Combination Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Artemisinin Combination Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Artemisinin Combination Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Artemisinin Combination Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Artemisinin Combination Therapy Industry Development
Chapter 3 Artemisinin Combination TherapyIndustry Chain Analysis
-
3.1 Artemisinin Combination Therapy Industry Chain
-
3.2 Artemisinin Combination Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Artemisinin Combination Therapy Market
-
3.3 Artemisinin Combination Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Artemisinin Combination Therapy Market
Chapter 4 China Artemisinin Combination Therapy Market, by Type
-
4.1 China Artemisinin Combination Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Artemisinin Combination Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Artemisinin Combination Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Artemisinin Combination Therapy Production Volume and Growth Rate of Artemether-Lumefantrine
-
4.5.2 China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Amodiaquine
-
4.5.3 China Artemisinin Combination Therapy Production Volume and Growth Rate of Others
-
4.5.4 China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Sulfadoxine-Pyrimethamine
-
4.5.5 China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Pyronaridine
Chapter 5 China Artemisinin Combination Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Artemisinin Combination Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Artemisinin Combination Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Artemisinin Combination Therapy Market Size and Growth Rate of Clinic
-
5.5.2 China Artemisinin Combination Therapy Market Size and Growth Rate of Hospital
-
5.5.3 China Artemisinin Combination Therapy Market Size and Growth Rate of Other
Chapter 6 China Artemisinin Combination Therapy Market, by Region
-
6.1 China Artemisinin Combination Therapy Production Volume and Production Value, by Region
-
6.2 China Artemisinin Combination Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Artemisinin Combination Therapy Market Analysis
-
7.1 North China Artemisinin Combination Therapy Market, by Type
-
7.2 North China Artemisinin Combination Therapy Market, by Application
Chapter 8 Central China Artemisinin Combination Therapy Market Analysis
-
8.1 Central China Artemisinin Combination Therapy Market, by Type
-
8.2 Central China Artemisinin Combination Therapy Market, by Application
Chapter 9 South China Artemisinin Combination Therapy Market Analysis
-
9.1 South China Artemisinin Combination Therapy Market, by Type
-
9.2 South China Artemisinin Combination Therapy Market, by Application
Chapter 10 East China Artemisinin Combination Therapy Market Analysis
-
10.1 East China Artemisinin Combination Therapy Market, by Type
-
10.2 East China Artemisinin Combination Therapy Market, by Application
Chapter 11 Northeast China Artemisinin Combination Therapy Market Analysis
-
11.1 Northeast China Artemisinin Combination Therapy Market, by Type
-
11.2 Northeast China Artemisinin Combination Therapy Market, by Application
Chapter 12 Southwest China Artemisinin Combination Therapy Market Analysis
-
12.1 Southwest China Artemisinin Combination Therapy Market, by Type
-
12.2 Southwest China Artemisinin Combination Therapy Market, by Application
Chapter 13 Northwest China Artemisinin Combination Therapy Market Analysis
-
13.1 Northwest China Artemisinin Combination Therapy Market, by Type
-
13.2 Northwest China Artemisinin Combination Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Sanofi
-
14.1.1 Sanofi Company Profile
-
14.1.2 Sanofi Artemisinin Combination Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Ipca Laboratories
-
14.2.1 Ipca Laboratories Company Profile
-
14.2.2 Ipca Laboratories Artemisinin Combination Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Calyx Chemicals and Pharmaceuticals
-
14.3.1 Calyx Chemicals and Pharmaceuticals Company Profile
-
14.3.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Ajanta Pharma
-
14.4.1 Ajanta Pharma Company Profile
-
14.4.2 Ajanta Pharma Artemisinin Combination Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Hovid Berhad
-
14.5.1 Hovid Berhad Company Profile
-
14.5.2 Hovid Berhad Artemisinin Combination Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Shanghai Fosun Pharmaceutical Industrial Development
-
14.6.1 Shanghai Fosun Pharmaceutical Industrial Development Company Profile
-
14.6.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Aspen Pharmacare Holdings
-
14.7.1 Aspen Pharmacare Holdings Company Profile
-
14.7.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Desano Holdings
-
14.8.1 Desano Holdings Company Profile
-
14.8.2 Desano Holdings Artemisinin Combination Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 KPC Pharmaceuticals
-
14.9.1 KPC Pharmaceuticals Company Profile
-
14.9.2 KPC Pharmaceuticals Artemisinin Combination Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis
-
14.10.1 Novartis Company Profile
-
14.10.2 Novartis Artemisinin Combination Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Cipla
-
14.11.1 Cipla Company Profile
-
14.11.2 Cipla Artemisinin Combination Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Guilin Pharmaceuticals
-
14.12.1 Guilin Pharmaceuticals Company Profile
-
14.12.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Artemisinin Combination Therapy Industry Research Conclusions
-
15.2 Artemisinin Combination Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Artemisinin Combination Therapy Industry Market Size (2018-2029)
-
Figure China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artemether-Lumefantrine (2018-2029)
-
Figure China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Amodiaquine (2018-2029)
-
Figure China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Sulfadoxine-Pyrimethamine (2018-2029)
-
Figure China Artemisinin Combination Therapy Production Volume, Production Value and Growth Rate of Artesunate-Pyronaridine (2018-2029)
-
Figure China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Artemisinin Combination Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Artemisinin Combination Therapy Market Size and Growth Rate from 2018-2029
-
Figure Artemisinin Combination Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Artemisinin Combination Therapy Market Share by Type in 2018
-
Figure China Artemisinin Combination Therapy Market Share by Type in 2023
-
Figure China Artemisinin Combination Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume and Growth Rate of Artemether-Lumefantrine (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Amodiaquine (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Sulfadoxine-Pyrimethamine (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume and Growth Rate of Artesunate-Pyronaridine (2018-2023)
-
Figure China Artemisinin Combination Therapy Market Share by Application in 2018
-
Figure China Artemisinin Combination Therapy Market Share by Application in 2023
-
Figure China Artemisinin Combination Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Artemisinin Combination Therapy Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Artemisinin Combination Therapy Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Artemisinin Combination Therapy Market Size and Growth Rate of Other (2018-2023)
-
Table China Artemisinin Combination Therapy Production Volume by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Production Volume Share by Region (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Volume Share by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Production Value by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Production Value Share by Region (2018-2023)
-
Figure China Artemisinin Combination Therapy Production Value Share by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Sales Volume by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Artemisinin Combination Therapy Sales Volume Share by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Sales Value by Region (2018-2023)
-
Table China Artemisinin Combination Therapy Sales Value Share by Region (2018-2023)
-
Figure China Artemisinin Combination Therapy Sales Value Share by Region (2018-2023)
-
Table North China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table North China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table North China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table North China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table Central China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table Central China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table South China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table South China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table South China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table East China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table East China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table East China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Artemisinin Combination Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Artemisinin Combination Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Artemisinin Combination Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Artemisinin Combination Therapy Sales Volume Share by Application (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Ipca Laboratories Company Profile
-
Table Ipca Laboratories Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Calyx Chemicals and Pharmaceuticals Company Profile
-
Table Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Ajanta Pharma Company Profile
-
Table Ajanta Pharma Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Hovid Berhad Company Profile
-
Table Hovid Berhad Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Shanghai Fosun Pharmaceutical Industrial Development Company Profile
-
Table Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Aspen Pharmacare Holdings Company Profile
-
Table Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Desano Holdings Company Profile
-
Table Desano Holdings Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table KPC Pharmaceuticals Company Profile
-
Table KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Cipla Company Profile
-
Table Cipla Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
Table Guilin Pharmaceuticals Company Profile
-
Table Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Price and Gross (2018-2023)
-
